Latest Insider Transactions at Nuvalent, Inc. (NUVL)
This section provides a real-time view of insider transactions for Nuvalent, Inc. (NUVL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Nuvalent, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Nuvalent, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 15
2024
|
Emily Conley |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+49.96%
|
$45,000
$9.36 P/Share
|
|
Apr 15
2024
|
Matthew Shair |
SELL
Open market or private sale
|
Direct |
37,500
-1.17%
|
$2,437,500
$65.72 P/Share
|
|
Apr 08
2024
|
Matthew Shair |
SELL
Open market or private sale
|
Direct |
37,500
-0.76%
|
$2,550,000
$68.72 P/Share
|
|
Apr 04
2024
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,000
-2.12%
|
$219,000
$73.2 P/Share
|
|
Apr 04
2024
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+7.63%
|
$18,000
$6.89 P/Share
|
|
Apr 01
2024
|
Matthew Shair |
SELL
Open market or private sale
|
Direct |
37,500
-1.12%
|
$2,887,500
$77.01 P/Share
|
|
Mar 28
2024
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
22,000
-14.73%
|
$1,650,000
$75.13 P/Share
|
|
Mar 28
2024
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,000
+17.96%
|
$506,000
$23.39 P/Share
|
|
Mar 27
2024
|
Andrew A. F. Hack |
SELL
Open market or private sale
|
Indirect |
880,000
-12.58%
|
$65,120,000
$74.59 P/Share
|
|
Mar 25
2024
|
Matthew Shair |
SELL
Open market or private sale
|
Indirect |
2,000
-0.42%
|
$154,000
$77.06 P/Share
|
|
Mar 25
2024
|
Matthew Shair |
SELL
Open market or private sale
|
Direct |
37,500
-1.09%
|
$2,887,500
$77.06 P/Share
|
|
Mar 22
2024
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
20,000
-14.01%
|
$1,540,000
$77.97 P/Share
|
|
Mar 22
2024
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+17.28%
|
$140,000
$7.74 P/Share
|
|
Mar 15
2024
|
Emily Conley |
SELL
Open market or private sale
|
Direct |
13,333
-53.2%
|
$1,079,973
$81.69 P/Share
|
|
Mar 15
2024
|
Emily Conley |
BUY
Exercise of conversion of derivative security
|
Direct |
13,333
+49.99%
|
$119,997
$9.36 P/Share
|
|
Jan 05
2024
|
Christopher Durant Turner Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,300
+41.05%
|
-
|
|
Jan 05
2024
|
Deborah Ann Miller Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,300
+50.0%
|
-
|
|
Jan 05
2024
|
Darlene Noci Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,300
+50.0%
|
-
|
|
Jan 05
2024
|
James Richard Porter President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
112,800
+37.49%
|
-
|
|
Jan 05
2024
|
Alexandra Balcom Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,300
+50.0%
|
-
|
|
Dec 28
2023
|
Matthew Shair |
SELL
Open market or private sale
|
Direct |
48,548
-1.38%
|
$3,641,100
$75.67 P/Share
|
|
Dec 27
2023
|
Matthew Shair |
SELL
Open market or private sale
|
Direct |
1,000
-0.06%
|
$75,000
$75.17 P/Share
|
|
Dec 26
2023
|
Matthew Shair |
SELL
Open market or private sale
|
Direct |
69,602
-1.89%
|
$5,150,548
$74.67 P/Share
|
|
Dec 19
2023
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$375,000
$75.0 P/Share
|
|
Dec 19
2023
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$90,000
$18.93 P/Share
|
|
Dec 18
2023
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
40,000
-100.0%
|
$3,000,000
$75.82 P/Share
|
|
Dec 18
2023
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+29.34%
|
$280,000
$7.46 P/Share
|
|
Dec 18
2023
|
Anna Protopapas |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$375,000
$75.67 P/Share
|
|
Dec 18
2023
|
Anna Protopapas |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$45,000
$9.36 P/Share
|
|
Dec 18
2023
|
Alexandra Balcom Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
30,000
-100.0%
|
$2,250,000
$75.82 P/Share
|
|
Dec 18
2023
|
Alexandra Balcom Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+50.0%
|
$30,000
$1.08 P/Share
|
|
Dec 18
2023
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
33,046
-100.0%
|
$2,478,450
$75.82 P/Share
|
|
Dec 18
2023
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,046
+50.0%
|
$892,242
$27.85 P/Share
|
|
Nov 28
2023
|
Matthew Shair |
SELL
Open market or private sale
|
Direct |
9,150
-0.25%
|
$567,300
$62.03 P/Share
|
|
Nov 01
2023
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,000
-56.47%
|
$156,000
$52.31 P/Share
|
|
Nov 01
2023
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+50.0%
|
$3,000
$1.08 P/Share
|
|
Oct 24
2023
|
Matthew Shair |
SELL
Open market or private sale
|
Direct |
91,700
-2.37%
|
$4,585,000
$50.93 P/Share
|
|
Oct 04
2023
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
20,000
-86.5%
|
$1,120,000
$56.48 P/Share
|
|
Oct 04
2023
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+46.76%
|
$60,000
$3.99 P/Share
|
|
Oct 04
2023
|
Christopher Durant Turner Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,995
-6.97%
|
$439,725
$55.01 P/Share
|
|
Oct 04
2023
|
Christopher Durant Turner Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,995
+26.21%
|
$47,970
$6.89 P/Share
|
|
Oct 02
2023
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,000
-73.3%
|
$138,000
$46.12 P/Share
|
|
Oct 02
2023
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+50.0%
|
$3,000
$1.08 P/Share
|
|
Sep 15
2023
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,000
-81.1%
|
$94,000
$47.71 P/Share
|
|
Sep 15
2023
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$12,000
$6.89 P/Share
|
|
Sep 01
2023
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,000
-70.0%
|
$138,000
$46.49 P/Share
|
|
Sep 01
2023
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+50.0%
|
$3,000
$1.08 P/Share
|
|
Aug 15
2023
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,000
-82.28%
|
$84,000
$42.73 P/Share
|
|
Aug 15
2023
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$12,000
$6.89 P/Share
|
|
Aug 01
2023
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,000
-66.07%
|
$147,000
$49.88 P/Share
|